Evidence map›Paper›PMID 40780811›Full record

ArticleAIDS patient care and STDs2025

Implementation Determinants of HIV Testing and Pre-Exposure Prophylaxis in Community Pharmacies in Philadelphia, PA.

Cedric H Bien-Gund, Anna Sweeney, Brandon Ptak, Michelle Jeon, David Koren, Javontae Williams, Kathleen A Brady, Jose Bauermeister, Sarah M Wood

Abstract read
In one paragraph

Article in AIDS patient care and STDs, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Cedric H Bien-GundDivision of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-0182-5680
Anna SweeneySchool of Nursing, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Brandon PtakDepartment of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0009-0001-9576-4972
Michelle JeonSchool of Health Professions, Philadelphia College of Pharmacy, Saint Joseph's University, Philadelphia, Pennsylvania, USA.
David KorenDepartment of Pharmacy Practice, School of Pharmacy, Temple University, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-6601-9893
Javontae WilliamsDivision of HIV Health, Philadelphia Department of Public Health, Philadelphia, Pennsylvania, USA.
Kathleen A BradyDivision of HIV Health, Philadelphia Department of Public Health, Philadelphia, Pennsylvania, USA.
Jose BauermeisterLeonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sarah M WoodDivision of Adolescent Medicine, Icahn School of Medicine, Mount Sinai, New York, USA.

Funding

Virus & Reservoirs CoreP30AI045008 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI Ronald G Collman · 1999 to 2026
$78.6M
Health Coaching to Improve Comprehensive HIV and Sexually Transmitted Infection Prevention in Adolescent Primary CareK23MH119976 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI WOOD, SARAH MARIAN · 2020 to 2024
$926k
Promoting linkage to PrEP after HIV self-testing through a peer-led intervention for MSMK23MH131468 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI Cedric Howshan Bien-Gund · 2023 to 2026
$778k
NIAID NIH HHS P30 AI045008NIMH NIH HHS K23 MH119976NIMH NIH HHS K23 MH131468
6 · The paper itself

Abstract

Delivering HIV testing and pre-exposure prophylaxis (PrEP) in community pharmacies can expand access to HIV services for populations with limited access to care. However, few pharmacies in the United States have successfully implemented these services. We investigated implementation barriers and facilitators of pharmacy-based HIV testing and PrEP initiation in Philadelphia, an Ending the HIV Epidemic priority jurisdiction with high rates of HIV and bacterial STIs, located in a state with relatively restrictive laws governing pharmacy scope of practice. Using a sequential, exploratory mixed-methods study design, we conducted 15 in-depth interviews with pharmacists and key implementing partners, followed by an online survey of pharmacists, pharmacy students, and technicians (

Indexed as

Anti-HIV AgentsCommunity Pharmacy ServicesHIV InfectionsHIV TestingPharmaciesPre-Exposure ProphylaxisAdultFemaleHealth Services AccessibilityHumansInterviews as TopicMalePharmacistsPhiladelphiaSurveys and QuestionnairesAnti-HIV AgentsConsolidated Framework for Implementation ResearchHIV preventionHIV testingimplementation determinantspharmacypre-exposure prophylaxis

Identifiers

PMID40780811
PMCPMC12593231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.